NCT06117098

Brief Summary

The aim of this feasibility study is to investigate whether a full scale RCT on the efficacy of a mobile app for risk reduction on type 2 diabetes can be conducted in the way it is planned or whether it needs to be modified. This will be investigated through a feasibility study (small scale RCT) on the efficacy of mobile technology on risk reduction of type 2 diabetes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 2, 2023

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

May 31, 2023

Completed
5 months until next milestone

First Posted

Study publicly available on registry

November 3, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

November 3, 2023

Status Verified

March 1, 2023

Enrollment Period

8 months

First QC Date

May 31, 2023

Last Update Submit

October 31, 2023

Conditions

Keywords

Prevention

Outcome Measures

Primary Outcomes (5)

  • Recruitment rate

    We want to assess the proportion of participants willing and able to take part in the study after referral from general practitioner in two different regions in East Norway. Information will be recorded continuously after telephone contact.

    Six months

  • Resources

    We will assess the randomization procedure and asses time spent on the first consultation with the participants. Throughout the study period, the supervisor will log all time spent monitoring participants and giving individual feedback through the app.

    Nine months

  • Management

    The use of the app will be registered in terms of actual use and if patients answered tasks within a week, all based on data shown in the administrator interface. Data on adherence to provided tasks and problems experienced with the mobile app will be retrieved from the app-database. We will also assess whether there are any problems with data management involved in the study and assess whether the study personnel had any challenges in conduct of the study.

    Nine months

  • Satisfaction with the app

    User satisfaction with the application will be assessed with the System Usability Scale. (SUS), a paper questionnaire at the end of the intervention.The SUS is a technology independent, 10-item questionnaire with a score between 0 and 100 were 0 represents low usability and 100 represent high usability. We will also asses the experienced usefulness of the app after 12 weeks. This will be measured through a questionnaire designed for this study consisting of 16 questions; 13 questions with answers on a Likert scale (0 to 100), 3 multiple-choice questions, and 1 open-ended question.

    Three months

  • Change and ceiling and floor effect in outcomes

    These outcomes will be determined by evaluating whether changes in quality of life and physical activity over a 12-week period could be observed and whether these outcomes disclose ceiling or floor effects. To assess these domains, we will use part of standard questionnaires being used in Healthy Life Centers at the beginning and ending of a 12-week intervention period, being the COOP/WONCA (the Dartmount COOP/World Organization of Family Doctors functional health assessment). This is a questionnaire assessing changes in quality of life.It consists of six questions across six domains with a score of 1 in each domain representing the best possible score while a score of 5 is the worst possible score. Physical activity will be assessed with the validated International Physical Activity Questionnaire (IPAQ) short form. It consists of eight items and encompasses questions regarding time spent walking, in moderate and vigorous intensity physical activity, besides sitting time.

    Three months

Secondary Outcomes (1)

  • Antropometric measures

    Three months

Study Arms (3)

Mobile application

EXPERIMENTAL

This group will receive individual guidance via the mobile application (12 weeks)

Device: Mobile application

Group-based lifestyle intervention at the Healthy Lifestyle Centres

ACTIVE COMPARATOR

This group will receive a group-based lifestyle intervention program at a Healthy Lifestyle Centre (12 weeks)

Behavioral: Group-based lifestyle intervention

Group-based lifestyle intervention at a Healthy Lifestyle Centre and recieving a mobile application

EXPERIMENTAL

This group will receive a group-based lifestyle intervention program at a Healthy Lifestyle Centre plus the mobile application (12 weeks)

Behavioral: Group-based lifestyle intervention at a Healthy Lifestyle Centre + mobile application"

Interventions

Individual lifestyle intervention via an mobile application

Mobile application

Group-based lifestyle intervention at a Healthy Lifestyle Centre + mobile application"

Group-based lifestyle intervention at a Healthy Lifestyle Centre and recieving a mobile application

Group-based life style intervention at a Healthy Lifestyle Centre (ususal care)

Group-based lifestyle intervention at the Healthy Lifestyle Centres

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • smart phone
  • prediabetes

You may not qualify if:

  • not interested in lifestyle change

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

OsloMet

Oslo, Norway

RECRUITING

MeSH Terms

Conditions

Prediabetic State

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Birgitta Blakstad Nilsson, Phd

    OsloMet

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Birgitta Blakstad Nilsson, Phd

CONTACT

Gyri Skoglund, Msc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: RCT feasibility study, non-inferiority and superiority trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 31, 2023

First Posted

November 3, 2023

Study Start

May 2, 2023

Primary Completion

December 31, 2023

Study Completion

June 30, 2024

Last Updated

November 3, 2023

Record last verified: 2023-03

Locations